Sign Up Today and Learn More About YolTech Therapeutics Stock
Invest in or calculate the value of your shares in YolTech Therapeutics or other pre-IPO companies through EquityZen's platform.
YolTech Therapeutics Stock
Yaotang Bio is a biotechnology company focusing on combining LNP delivery and gene editing technology.
About YolTech Therapeutics Stock
Founded
2021
Industries
Software, Artificial Intelligence, Data and Analytics
YolTech Therapeutics Press Mentions
Stay in the know about the latest news on YolTech Therapeutics
Gene Editing Market is Expected to Grow USD 22.87 Billion by 2032 | At CAGR 12.06%
einpresswire • Feb 10, 2026
YolTech Therapeutics: $45 Million Series B Raised For In-Body Gene Editing Treatments
pulse2 • Sep 14, 2025
YolTech Therapeutics Raises $45 Million in Series B Financing Led by AstraZeneca-CICC
biospace • Sep 12, 2025
YolTech Therapeutics Raises $45 Million in Series B Financing Led by AstraZeneca-CICC
citybiz • Sep 12, 2025
YolTech Therapeutics Raises $45 Million in Series B Financing Led by AstraZeneca-CICC
morningstar • Sep 12, 2025
Join now and verify your accreditation status to gain access to:
- YolTech Therapeutics Current Valuation
- YolTech Therapeutics Stock Price
- YolTech Therapeutics Management
- Available deals in YolTech Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- YolTech Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- YolTech Therapeutics Revenue and Financials
- YolTech Therapeutics Highlights
- YolTech Therapeutics Business Model
- YolTech Therapeutics Risk Factors
- YolTech Therapeutics Research Report from SACRA Research
Trading YolTech Therapeutics Stock
How to invest in YolTech Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like YolTech Therapeutics through EquityZen funds. These investments are made available by existing YolTech Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell YolTech Therapeutics stock?
Shareholders can sell their YolTech Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."